Key result
Maternal pulmonary hypertension and cardiomyopathy are linked to ~50% higher risk of hypertensive pregnancy disorders.
Why the study?
Data were limited regarding the degree of preeclampsia risk and the impact of hypertensive disorders of pregnancy on gestational age at delivery in pregnant patients with cardiovascular disease.
Does cardiovascular disease increase the risk of hypertensive disorders of pregnancy and preterm delivery in pregnant patients?
Cohort (n=4,606,247)
Yes
Does cardiovascular disease increase the risk of hypertensive disorders of pregnancy and preterm delivery in pregnant patients?
Effect estimate: aOR 1.5 (95% CI 1.3-1.8)
Pregnant patients with cardiovascular disease, particularly pulmonary hypertension and cardiomyopathy, have a significantly higher risk of hypertensive disorders of pregnancy and earlier delivery.
May support intensified HDP surveillance in pregnant patients with pulmonary hypertension or cardiomyopathy; leaves open optimal management strategies.
Background: Pregnant patients with cardiovascular disease (CVD) face increased risk of preeclampsia and preterm delivery, yet data is limited data regarding degree of risk and impact of hypertensive disorders of pregnancy (HDP) on gestational age at delivery. Objectives: To examine HDP risk and impact on delivery timing in patients with CVD. Methods: This retrospective cohort study included patients >18 years old who delivered between 10/1/2015 and 12/31/2020 using the Premier Healthcare Database. Patients with CVD were divided into six categories: congenital, ischemic, aortic pathology, pulmonary hypertension, cardiomyopathy, and valvular disease. The primary outcome was risk of HDP (gestational hypertension/ preeclampsia). The secondary outcome was gestational age at delivery. Multivariable mixed effects regression models were used to estimate adjusted outcomes, adjusting for CVD subtype, >1 CVD subtype present, demographics, hospital characteristics, and comorbidities. Results: Among 4,606,247 obstetric patients, 20,021 had CVD. The risk of HDP among people with CVD varied by CVD subtype, lowest in those with congenital heart disease (aOR,0.9; 95% CI [0.8, 1.0]) and highest in those with pulmonary hypertension (aOR, 1.5; 95% CI [1.3, 1.8]) and cardiomyopathy (aOR,1.5; 95% CI [1.4,1.6]). Patients with CVD delivered earlier than those without CVD, even in the absence of HDP(36.4-38.0 weeks versus 38.4 weeks). Among those with HDP, patients with severe pre-eclampsia with CVD, delivered earlier than those without CVD (33.1-34.6 weeks versus 35.5 weeks). Conclusion: Risk of HDP and preterm delivery is higher those with CVD, particularly in pulmonary hypertension and cardiomyopathy. Patients with CVD should be advised of their increased risk.
No takes yet. Share an insight, caveat, or question.
Jones et al. (2025) conducted a cohort in Cardiovascular disease in pregnancy (n=4,606,247). Cardiovascular disease vs. No cardiovascular disease was evaluated on Risk of hypertensive disorders of pregnancy (gestational hypertension/preeclampsia) (aOR 1.5, 95% CI 1.3-1.8). Cardiovascular disease in pregnancy increased the risk of hypertensive disorders, peaking in pulmonary hypertension (aOR 1.5; 95% CI 1.3-1.8) and cardiomyopathy (aOR 1.5; 95% CI 1.4-1.6).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: